Clinical Trials
14 trialsNCT04169074 2026-05-22
Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
University of Arizona
Phase 2 Terminated
NCT04116320 2025-07-14
AM-003
University of Virginia
Phase 1 Terminated
NCT04496674 2025-04-23
2019-004849-32
German Cancer Research Center
Phase 1/2 Terminated
NCT03685591 2024-06-26
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT01234480 2023-05-16
Intended Use Study of the BD SurePath Plusâ„¢ Pap
Becton, Dickinson and Company
Terminated
NCT02376699 2023-05-01
Safety Study of SEA-CD40 in Cancer Patients
Seagen Inc.
Phase 1 Terminated
NCT02837042 2022-06-21
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
University of Alabama at Birmingham
Phase 2 Terminated
NCT03937791 2021-04-13
Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01111058 2020-04-07
Everolimus Versus Placebo in Head and Neck Cancer
University of Chicago
Phase 2 Terminated
NCT00591149 2017-06-14
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
University of Kansas Medical Center
Phase 2 Terminated
NCT00272181 2015-12-23
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Sesen Bio, Inc.
Phase 2 Terminated
NCT00412776 2015-12-23
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Sesen Bio, Inc.
Phase 2/3 Terminated
NCT00401401 2011-12-23
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
Genmab
Phase 1/2 Terminated
NCT00559351 2007-11-16
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
Ministry of Scientific Research and Information Technology, Poland
Phase 3 Terminated